ethylisopropylamiloride has been researched along with Atrial Fibrillation in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasilets, LA | 1 |
| Mokh, VP | 1 |
| Khodorov, BI | 1 |
1 other study available for ethylisopropylamiloride and Atrial Fibrillation
| Article | Year |
|---|---|
[Prevention of reperfusion-induced arrhythmia by Na+/H+ exchange block].
Topics: Amiloride; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Hydrogen-Ion Concentration; In Vitr | 1989 |